->1 million children
-Result: No increased risk of autism, asthma, or autoimmune diseases in vaccinated vs unvaccinated children
en.ssi.dk/news/news/20...
[9/9]
->1 million children
-Result: No increased risk of autism, asthma, or autoimmune diseases in vaccinated vs unvaccinated children
en.ssi.dk/news/news/20...
[9/9]
-10 studies , >1.2 million children
-Result: Pooled OR for ASD after vaccines ~0.99 (95% CI 0.92–1.06). Authors conclude no evidence of increased risk of ASD or autism with any vaccine exposure.
pubmed.ncbi.nlm.nih.gov/24814559/
[8/9]
-10 studies , >1.2 million children
-Result: Pooled OR for ASD after vaccines ~0.99 (95% CI 0.92–1.06). Authors conclude no evidence of increased risk of ASD or autism with any vaccine exposure.
pubmed.ncbi.nlm.nih.gov/24814559/
[8/9]
-Review of available epidemiology on thimerosal and ASD.
-Result: Studies “do not demonstrate a link” between thimerosal-containing vaccines and ASD; PK of ethylmercury makes such a causal link biologically unlikely.
publications.aap.org/pediatrics/a...
[7/9]
-Review of available epidemiology on thimerosal and ASD.
-Result: Studies “do not demonstrate a link” between thimerosal-containing vaccines and ASD; PK of ethylmercury makes such a causal link biologically unlikely.
publications.aap.org/pediatrics/a...
[7/9]
-Large HMO database, multiple neurodevelopmental outcomes.
-Result: “No consistent significant associations” between thimerosal-containing vaccines and neurodevelopmental outcomes
pubmed.ncbi.nlm.nih.gov/14595043/
[6/9]
-Large HMO database, multiple neurodevelopmental outcomes.
-Result: “No consistent significant associations” between thimerosal-containing vaccines and neurodevelopmental outcomes
pubmed.ncbi.nlm.nih.gov/14595043/
[6/9]
-Case–control study using Japanese data.
-Looked at timing of MMR and cumulative thimerosal dose.
-Result: “No convincing evidence” that MMR or increasing thimerosal dose is associated with ASD onset.
pubmed.ncbi.nlm.nih.gov/25562790/
[5/9]
-Case–control study using Japanese data.
-Looked at timing of MMR and cumulative thimerosal dose.
-Result: “No convincing evidence” that MMR or increasing thimerosal dose is associated with ASD onset.
pubmed.ncbi.nlm.nih.gov/25562790/
[5/9]
~95K US children
-Compared ASD incidence by MMR status, including in those with an autistic older sibling.
-Result: No association between MMR and ASD in any group; no signal even in the high-risk subgroup.
pubmed.ncbi.nlm.nih.gov/25898051/
[4/9]
~95K US children
-Compared ASD incidence by MMR status, including in those with an autistic older sibling.
-Result: No association between MMR and ASD in any group; no signal even in the high-risk subgroup.
pubmed.ncbi.nlm.nih.gov/25898051/
[4/9]
-657K children
-Tested: overall risk, “susceptible” subgroups, and temporal clustering after MMR.
-Result: No increased risk for autism, no triggering in supposedly susceptible children, no clustering after vaccination
www.acpjournals.org/doi/10.7326/...
[3/9]
-657K children
-Tested: overall risk, “susceptible” subgroups, and temporal clustering after MMR.
-Result: No increased risk for autism, no triggering in supposedly susceptible children, no clustering after vaccination
www.acpjournals.org/doi/10.7326/...
[3/9]
-> 537K Danish children
-Compared autism rates in MMR-vaccinated vs unvaccinated
-Result: No increased risk of autism among vaccinated children
-“provides strong evidence against” the hypothesis that MMR causes autism
www.nejm.org/doi/full/10....
[2/9]
-> 537K Danish children
-Compared autism rates in MMR-vaccinated vs unvaccinated
-Result: No increased risk of autism among vaccinated children
-“provides strong evidence against” the hypothesis that MMR causes autism
www.nejm.org/doi/full/10....
[2/9]